neurological

R&D

Epilepsy affects women differently than men, owing to the complexity of brain health and the historical lack of investment in women’s health.

Views & Analysis

Getting a diagnosis is often the biggest challenge facing a rare disease patient in the UK.

News

AstraZeneca has staked a claim to the increasingly crowded IgAN market with an accelerated approval from the FDA for Ultomiris, its fifth indication.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.